报告期 | 净资产收益率 | 同比 | 环比 | 行业排名 | 行业均值 | 行业龙头股 | 龙头股该指标值 | 查看 |
---|---|---|---|---|---|---|---|---|
2025-03-31 | 4.66% | -18.25% | -54.36% | 11/69 | 2.26% | 沃华医药 | 5.94% | 行业排名> |
2024-12-31 | 10.21% | -29.78% | -15.2% | 17/69 | 3.28% | 天目药业 | 9.27% | 行业排名> |
2024-09-30 | 12.04% | -6.96% | 31.58% | 13/69 | 3.08% | 天目药业 | 22.26% | 行业排名> |
2024-06-30 | 9.15% | -11.93% | 60.53% | 9/69 | 0.67% | 羚锐制药 | 20.44% | 行业排名> |
2024-03-31 | 5.7% | -4.52% | -60.8% | 7/69 | 1.53% | 羚锐制药 | 13.25% | 行业排名> |
2023-12-31 | 14.54% | 23.85% | 12.36% | 11/69 | 0.11% | 片仔癀 | 7.03% | 行业排名> |
2023-09-30 | 12.94% | 17% | 24.54% | 12/69 | 7.26% | 片仔癀 | 23.1% | 行业排名> |
2023-06-30 | 10.39% | 43.51% | 74.04% | 9/69 | 4.93% | 太极集团 | 22.08% | 行业排名> |
2023-03-31 | 5.97% | 93.2% | -49.15% | 9/69 | 3.21% | 太极集团 | 17.13% | 行业排名> |
2022-12-31 | 11.74% | -3.45% | 6.15% | 22/69 | 6.65% | 以岭药业 | 10.43% | 行业排名> |
2022-09-30 | 11.06% | 1.37% | 52.76% | 14/69 | 5.16% | *ST吉药 | 72.63% | 行业排名> |
2022-06-30 | 7.24% | -1.76% | 134.3% | 13/69 | 3.2% | 片仔癀 | 23.54% | 行业排名> |
2022-03-31 | 3.09% | -14.17% | -74.59% | 20/69 | 2.18% | 片仔癀 | 19.69% | 行业排名> |
2021-12-31 | 12.16% | 7.42% | 11.46% | 17/69 | 4.54% | 片仔癀 | 12.75% | 行业排名> |
2021-09-30 | 10.91% | 27.01% | 48.03% | 17/69 | 7.54% | 片仔癀 | 6.88% | 行业排名> |
2021-06-30 | 7.37% | 26.85% | 104.72% | 14/69 | 4.68% | 片仔癀 | 27.39% | 行业排名> |
2021-03-31 | 3.6% | 16.13% | -68.2% | 17/69 | 2.7% | 片仔癀 | 23.14% | 行业排名> |
2020-12-31 | 11.32% | -2.41% | 31.78% | 16/69 | 0.1% | 片仔癀 | 13.23% | 行业排名> |
2020-09-30 | 8.59% | -2.05% | 47.85% | 25/69 | 6.79% | *ST长药 | 7.37% | 行业排名> |
2020-06-30 | 5.81% | -9.36% | 87.42% | 16/69 | 3.75% | 沃华医药 | 22.84% | 行业排名> |
2020-03-31 | 3.1% | -17.99% | -73.28% | 15/69 | 2.14% | 沃华医药 | 19.47% | 行业排名> |
2019-12-31 | 11.6% | 0.26% | 32.27% | 23/69 | 5.86% | 沃华医药 | 12.7% | 行业排名> |
2019-09-30 | 8.77% | 1.15% | 36.82% | 23/69 | 7.3% | 济川药业 | 7.33% | 行业排名> |
2019-06-30 | 6.41% | -3.03% | 69.58% | 18/69 | 4.72% | 济川药业 | 27.43% | 行业排名> |
2019-03-31 | 3.78% | -0.79% | -67.33% | 16/69 | 2.92% | 济川药业 | 23.05% | 行业排名> |
2018-12-31 | 11.57% | 21.66% | 33.45% | 23/69 | 7.87% | 济川药业 | 15.79% | 行业排名> |
2018-09-30 | 8.67% | 3.83% | 31.16% | 26/69 | 8.02% | 华润三九 | 10.23% | 行业排名> |
2018-06-30 | 6.61% | 26.87% | 73.49% | 22/69 | 5.03% | 济川药业 | 32.79% | 行业排名> |
2018-03-31 | 3.81% | 20.95% | -59.94% | 19/69 | 2.75% | 济川药业 | 27.55% | 行业排名> |
2017-12-31 | 9.51% | 12.28% | 13.89% | 36/69 | 9.93% | 济川药业 | 17.62% | 行业排名> |
2017-09-30 | 8.35% | -2.34% | 60.27% | 31/69 | 8.39% | 济川药业 | 10.07% | 行业排名> |
2017-06-30 | 5.21% | -13.6% | 65.4% | 34/69 | 5.24% | ST葫芦娃 | 46.01% | 行业排名> |
2017-03-31 | 3.15% | 4.65% | -62.81% | 25/69 | 2.62% | 济川药业 | 24.2% | 行业排名> |
2016-12-31 | 8.47% | -18.48% | -0.94% | 42/69 | 10.02% | *ST大药 | 15.31% | 行业排名> |
2016-09-30 | 8.55% | -20.32% | 41.79% | 29/69 | 9.32% | 济川药业 | 14.64% | 行业排名> |
2016-06-30 | 6.03% | -16.37% | 100.33% | 28/69 | 5.04% | 济川药业 | 7.64% | 行业排名> |
2016-03-31 | 3.01% | -28.67% | -71.03% | 27/69 | 4.1% | 维康药业 | 38.23% | 行业排名> |
2015-12-31 | 10.39% | -21.82% | -3.17% | 37/69 | 11.34% | 太极集团 | 58.41% | 行业排名> |
2015-09-30 | 10.73% | 6.13% | 48.82% | 22/69 | 8.44% | 新光药业 | 16.54% | 行业排名> |
2015-06-30 | 7.21% | -7.56% | 70.85% | 25/69 | 5.48% | 太极集团 | 71.6% | 行业排名> |
2015-03-31 | 4.22% | 1.93% | -68.25% | 15/69 | 2.9% | 维康药业 | 48.67% | 行业排名> |